Israel - anglès - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - ropeginterferon alfa-2b - solution for injection - ropeginterferon alfa-2b 500 mcg/ml - ropeginterferon alfa-2b - besremi is indicated as monotherapy in adults for the treatment of polycythaemia vera without symptomatic splenomegaly.

Israel - anglès - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - ropeginterferon alfa-2b - solution for injection - ropeginterferon alfa-2b 1000 mcg/ml - ropeginterferon alfa-2b - besremi is indicated as monotherapy in adults for the treatment of polycythaemia vera without symptomatic splenomegaly.

Unió Europea - anglès - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - tetrabenazine - oral tablet - 25mg

Israel - anglès - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - argipressin - concentrate for solution for infusion - argipressin 40 iu / 2 ml - argipressin - embesin is indicated for the treatment of catecholamine-refractory hypotension following septic shock in patients older than 18 years. a catecholamine-refractory hypotension is present if the mean arterial blood pressure cannot be stabilized to 65 – 75 mmhg despite adequate volume substitution and application of catecholamines.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - naltrexone hydrochloride - oral tablet - 50mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - tetrabenazine - oral tablet - 25mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - naltrexone hydrochloride - oral tablet - 50mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - esmolol hydrochloride - solution for injection - 10mg/1ml

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - esmolol hydrochloride - powder for solution for infusion - 2.5gram